+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 19Years +
All Genders
ID07275827

Comparing Proton Pump Inhibitor and Vonoprazan Triple Therapies With or Without Zinc for Helicobacter pylori Infection Treatment

Led by Tanta University · Updated on 2026-09-09

88

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of different triple therapy treatments to eradicate Helicobacter pylori infection, a bacterium that colonizes the stomach and can lead to serious gastrointestinal diseases including chronic gastritis, peptic ulcers, and gastric cancer. This phase 3 randomized controlled study compares proton pump inhibitor PPI based therapy and vonoprazan-based therapy, both with or without zinc supplementation, to determine their impact on H. pylori eradication and related biological markers. The study involves four treatment groups of 22 patients each. One group receives PPI-based triple therapy with omeprazole or pantoprazole, amoxicillin, and clarithromycin twice daily for 14 days, with another group receiving the same therapy plus zinc sulfate. The other two groups receive vonoprazan-based triple therapy with amoxicillin and clarithromycin, with one group also receiving zinc sulfate. Zinc is being studied for its potential to inhibit H. pylori growth and enhance treatment efficacy. Successful eradication will be confirmed at least 4 weeks after treatment. Participants will be monitored over 8 weeks, with assessments including stool antigen tests to confirm H. pylori eradication and blood tests measuring serum interleukin-6 and pepsinogen levels to evaluate inflammation and gastric health. The Gastrointestinal Symptom Rating Scale is also used to track symptom changes. The study will assess differences in eradication rates and changes in biomarkers and symptoms, providing important data on the comparative effectiveness of therapies with and without zinc supplementation.

CONDITIONS

Brief Title

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

Research Team

E

Eman A Mahmoud, Prof.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here